Faculty Bibliography

Purpose : The ability to detect progression in eyes with advanced glaucoma is challenging because of known limitations of commonly used structural and functional parameters reaching their minimal measurable limit (floor effect) or increased measurement variability. We examined the ability of inner nuclear layer (INL) thickness measurements to demonstrate change longitudinally in eyes with early and advanced severity glaucoma. Methods : Subjects with glaucoma and >=4 visits were included in the study. Subjects in the ?Early/Moderate? group (EG) had average circumpapillary retinal nerve fiber layer (cRNFL) thicknesses >=60mum and subjects in the ?Advanced? group (AG) had average cRNFL thicknesses <=60mum. All subjects had comprehensive ophthalmic examination, Humphrey visual field (Zeiss, Dublin, CA) testing, and spectral-domain OCT (Cirrus HD-OCT; Zeiss) optic nerve head (ONH) and macula scans. Segmentation of the INL was performed using the Iowa Reference Algorithms (Retinal Image Analysis Lab, Iowa Institute for Biomedical Imaging, Iowa City, IA) and segmentation errors were manually corrected by a trained grader. Overall INL thickness along with the superior and inferior hemifields were used for analysis. Rates of progression were estimated from longitudinal OCT and visual field (VF) data using mixed effects models adjusting for baseline age, follow-up duration, and signal strength at each visit. Results : 23 eyes (23 subjects), 12 with EG and 11 with AG, were included in the study. At baseline, a statistically significant difference between groups was detected in MD, cRNFL, and GCIPL thicknesses (Table 1). In EG eyes, the rate of change was significantly different than a zero slope for cRNFL thickness, C:D ratio, and GCIPL thickness (Table 2). Inferior INL thickness was the only INL parameter showing significant rate of change. However, in the advanced group, all parameters (including both global and sectoral INL thicknesses) showed significant rate of change except for the cRNFL. Conclusions : Longitudinal measurements of INL thickness may be useful for following disease progression in subjects with advanced-stage glaucoma where cRNFL thickness is no longer useful

Purpose : Glaucoma is a widespread neurodegenerative disease affecting the retinal ganglion cells, optic nerve, distal visual pathways and beyond. Recent studies suggest that cerebrospinal fluid (CSF) plays a role in clearing wastes from the brain and that CSF dynamics may be altered in neurodegenerative diseases. Since CSF dynamics can be facilitated by the global brain activity, in the present study, we investigated how the dynamics of CSF and its coupling with global brain activity may be altered in glaucoma using functional magnetic resonance imaging (fMRI). Methods : 19 early glaucoma patients (62.3+/-1.7 yrs) (mean+/-SEM), 19 advanced glaucoma patients (64.7+/-2.4 yrs), and 19 healthy subjects (59+/-2.4 yrs) underwent anatomical MRI and resting-state fMRI with eyes closed. Age did not differ across groups (P=0.188). We extracted the CSF signal time profiles from the fourth ventricle (Fig. 1A) and the global brain activity [blood-oxygenation-level-dependent signal time profiles] from the entire gray matter (Fig. 1B). Following previous literature (Han F, et al. PLOS Biol 2021;19), the coupling between the CSF signals and the global brain activity (CSF-BOLD coupling) was examined via cross correlation at the 4s time lag, where more negative values indicate stronger coupling. We also associated these correlations with the volumes of the anterior visual pathway in anatomical MRI. Results : A significant group difference was observed in the power (i.e., strength) of the low frequency (0.01-0.03Hz) in the CSF signals (P=0.013; Fig.1C). Specifically, early glaucoma patients showed significantly greater power than advanced glaucoma patients (Bonferroni P=0.010). The power of the global brain activity showed similar trends but did not reach significance (P=0.390; Fig.1D). The CSF-BOLD coupling at the 4s lag differed significantly across groups (P=0.007; Fig. 1E). Early glaucoma patients had significantly stronger coupling than advanced glaucoma patients (Bonferroni P=0.025) and healthy controls (Bonferroni P=0.013). Further, CSF-BOLD coupling was correlated with the volumes of optic nerve (right: R=-0.342, P=0.009; left: R=-0.344, P=0.009, Fig. 2D,E) and optic chiasm (R=0.264, P=0.047, Fig. 2F). Conclusions : Our observations of the altered CSF dynamics and CSF-BOLD coupling provide physiological evidence to support the recent hypothesis of widespread brain involvements in the early stage of glaucoma

Purpose : Glaucoma is an eye disease with widespread involvement of the brain. Since visual cortex (VC) may possess lower choline levels in glaucoma, and basal forebrain (BF) has cholinergic projections to VC for modulating cerebral blood flow and visual processing, we postulate that the vascular functions of the VC and BF are involved in glaucoma (PMID: 31242454). Recently, we used a novel whole-brain relative cerebrovascular reactivity (rCVR) mapping technique via resting-state functional MRI (rsfMRI) without gas challenge, and observed rCVR decrease in VC and rCVR increase in BF in patients with increasing glaucoma severity (PMID: 34892116). However, the underlying mechanisms remain to be elucidated. Here, we applied a hydrogel-induced glaucoma mouse model to elevate intraocular pressure (IOP) (PMID: 31176841), mapped wholebrain rCVR using rsfMRI, and measured optomotor responses (OMR). We hypothesize that chronic IOP elevation can lead to rCVR changes in the glaucomatous brain along with visual impairments. Methods : For the glaucoma model, C57BL/6J mice (male, 15-weeks, n=15) received intracameral injection of cross-linking hydrogel to the right eye to obstruct aqueous outflow and induce chronic IOP elevation. Controls (male, 15-weeks, n=13) were untreated. IOP was measured in both eyes 2-3 times per week for 3 weeks, followed by OMR and rsfMRI experiments at 7 Tesla (Fig. 1A). Results : Sustained IOP elevation was confirmed in the right eyes of the glaucoma model (Fig. 1B). Over 90% of mouse optic nerve fibers are known to project to the contralateral visual brain; rCVR decreased in the left but not right VC, whereas rCVR increased in the right BF in the glaucoma model but not the controls (Fig. 2A). These rCVR changes were inversely coupled (Fig. 2B). In addition, IOP of the injected eye was inversely correlated with rCVR in the left VC, while positively correlated with rCVR in the right BF (Fig. 2C). OMR revealed a decrease in visual acuity and an increase in visual contrast threshold for the injected eye (Fig. 2D) indicating visual impairment. The decrease in visual acuity was inversely correlated with rCVR in the BF (Fig. 2E). Conclusions : Mouse rCVR mapping using rsfMRI detects widespread brain changes induced by chronic IOP elevation, and demonstrates vascular involvement in glaucoma both within and beyond the primary visual pathways

Purpose:The lamina cribrosa (LC) is a leading target for initial glaucomatous damage. We investigated the in vivo microstructural deformation within the LC volume in response to acute IOP modulation while maintaining fixed intracranial pressure (ICP). Methods:In vivo optic nerve head (ONH) spectral-domain optical coherence tomography (OCT) scans (Leica, Chicago, IL, USA) were obtained from eight eyes of healthy adult rhesus macaques (7 animals; ages = 7.9-14.4 years) in different IOP settings and fixed ICP (8-12 mm Hg). IOP and ICP were controlled by cannulation of the anterior chamber and the lateral ventricle of the brain, respectively, connected to a gravity-controlled reservoir. ONH images were acquired at baseline IOP, 30 mm Hg (H1-IOP), and 40 to 50 mm Hg (H2-IOP). Scans were registered in 3D, and LC microstructure measurements were obtained from shared regions and depths. Results:Only half of the eyes exhibited LC beam-to-pore ratio (BPR) and microstructure deformations. The maximal BPR change location within the LC volume varied between eyes. BPR deformer eyes had a significantly higher baseline connective tissue volume fraction (CTVF) and lower pore aspect ratio (P = 0.03 and P = 0.04, respectively) compared to BPR non-deformer. In all eyes, the magnitude of BPR changes in the anterior surface was significantly different (either larger or smaller) from the maximal change within the LC (H1-IOP: P = 0.02 and H2-IOP: P = 0.004). Conclusions:The LC deforms unevenly throughout its depth in response to IOP modulation at fixed ICP. Therefore, analysis of merely the anterior LC surface microstructure will not fully capture the microstructure deformations within the LC. BPR deformer eyes have higher CTVF than BPR non-deformer eyes.

We hypothesize that artificial intelligence applied to relevant clinical testing in glaucoma has the potential to enhance the ability to detect glaucoma. This premise was discussed at the recent Collaborative Community for Ophthalmic Imaging meeting, "The Future of Artificial Intelligence-Enabled Ophthalmic Image Interpretation: Accelerating Innovation and Implementation Pathways," held virtually September 3-4, 2020. The Collaborative Community in Ophthalmic Imaging (CCOI) is an independent self-governing consortium of stakeholders with broad international representation from academic institutions, government agencies, and the private sector whose mission is to act as a forum for the purpose of helping speed innovation in healthcare technology. It was one of the first two such organizations officially designated by the FDA in September 2019 in response to their announcement of the collaborative community program as a strategic priority for 2018-2020. Further information on the CCOI can be found online at their website (https://www.cc-oi.org/about). Artificial intelligence for glaucoma diagnosis would have high utility globally, as access to care is limited in many parts of the world and half of all people with glaucoma are unaware of their illness. The application of artificial intelligence technology to glaucoma diagnosis has the potential to broadly increase access to care worldwide, in essence flattening the Earth by providing expert level evaluation to individuals even in the most remote regions of the planet.

Glaucoma is the leading cause of global irreversible blindness, necessitating research for new, more efficacious treatment options than currently exist. Trabecular meshwork (TM) cells play an important role in the maintenance and function of the aqueous outflow pathway, and studies have found that there is decreased cellularity of the TM in glaucoma. Regeneration of the TM with stem cells has been proposed as a novel therapeutic option by several reports over the last few decades. Stem cells have the capacity for self-renewal and the potential to differentiate into adult functional cells. Several types of stem cells have been investigated in ocular regenerative medicine: tissue specific stem cells, embryonic stem cells, induced pluripotent stem cells, and adult mesenchymal stem cells. These cells have been used in various glaucoma animal models and ex vivo models and have shown success in IOP homeostasis and TM cellularity restoration. They have also demonstrated stability without serious side effects for a significant period of time. Based on current knowledge of TM pathology in glaucoma and existing literature regarding stem cell regeneration of this tissue, we propose a human clinical study as the next step in understanding this potentially revolutionary treatment paradigm. The ability to protect and replace TM cells in glaucomatous eyes could change the field forever.

Purpose/UNASSIGNED:The lamina cribrosa (LC) has an important role in the pathophysiology of ocular diseases. The purpose of this study is to characterize in vivo, noninvasively, and in 3D the structure of the LC in healthy non-human primates (NHPs). Methods/UNASSIGNED:Spectral-domain optical coherence tomography (OCT; Leica, Chicago, IL) scans of the optic nerve head (ONH) were obtained from healthy adult rhesus macaques monkeys. Using a previously reported semi-automated segmentation algorithm, microstructure measurements were assessed in central and peripheral regions of an equal area, in quadrants and depth-wise. Linear mixed-effects models were used to compare parameters among regions, adjusting for visibility, age, analyzable depth, graded scan quality, disc area, and the correlation between eyes. Spearmen's rank correlation coefficients were calculated for assessing the association between the lamina's parameters. Results/UNASSIGNED:Sixteen eyes of 10 animals (7 males and 3 females; 9 OD, 7 OS) were analyzed with a mean age of 10.5 ± 2.1 years. The mean analyzable depth was 175 ± 37 µm, with average LC visibility of 25.4 ± 13.0% and average disc area of 2.67 ± 0.45mm2. Within this volume, an average of 74.9 ± 39.0 pores per eye were analyzed. The central region showed statistically significantly thicker beams than the periphery. The quadrant-based analysis showed significant differences between the superior and inferior quadrants. The anterior LC had smaller beams and pores than both middle and posterior lamina. Conclusions/UNASSIGNED:Our study provides in vivo microstructure details of NHP's LC to be used as the foundation for future studies. We demonstrated mostly small but statistically significant regional variations in LC microstructure that should be considered when comparing LC measurements.

Purpose/UNASSIGNED:Vivid Vision Perimetry (VVP; Vivid Vision, Inc) is a novel method for performing in-office and home-based visual field assessment using a virtual reality platform and oculokinetic perimetry. Here we examine the reproducibility of VVP Swift and compare results with conventional standard automated perimetry (SAP) and spectral-domain (SD) OCT. Design/UNASSIGNED:Cross-sectional study. Participants/UNASSIGNED:Fourteen eyes of 7 patients with open-angle glaucoma (OAG) (average age, 64.6 years; 29% women) and 10 eyes of 5 patients with suspected glaucoma (average age, 61.8 years; 40% women) were enrolled. Methods/UNASSIGNED:Patients with OAG and suspected glaucoma were enrolled prospectively and underwent 2 VVP Swift examinations. Results were compared with 1 conventional SAP examination (Humphrey Visual Field [HVF]; Zeiss) and 1 SD OCT examination. Main Outcome Measures/UNASSIGNED:Mean sensitivity (in decibels) obtained for each eye in 2 VVP Swift test sessions and a conventional SAP examination, thickness of the retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) for the SD OCT examination, and mean test durations of the VVP Swift and SAP examinations. Results/UNASSIGNED:< 0.001), respectively. Conclusions/UNASSIGNED:Our results demonstrated that the VVP Swift test can generate reproducible results and is comparable with conventional SAP. This suggests that the device can be used by clinicians to assess visual function in glaucoma.

BACKGROUND:administration into both native and transplanted eyes. RESULTS: No significant intraocular pressure difference was found between native and transplanted eyes, whereas comparable manganese enhancement was observed between native and transplanted intraorbital optic nerves, suggesting the presence of anterograde manganese transport after WET. No enhancement was detected across the coaptation site in the higher visual areas of the recipient brain. Comparison with Existing Methods: Existing imaging methods to assess WET focus on either the eye or local optic nerve segments without direct visualization and longitudinal quantification of physiological transport along the transplanted visual pathway, hence the development of in vivo MEMRI. CONCLUSION/CONCLUSIONS: Our established imaging platform indicated that essential physiological transport exists in the transplanted optic nerve after WET. As neuroregenerative approaches are being developed to connect the transplanted eye to the recipient's brain, in vivo MEMRI is well-suited to guide strategies for successful WET integration for vision restoration. Keywords (Max 6): Anterograde transport, magnetic resonance imaging, manganese, neuroregeneration, optic nerve, whole-eye transplantation.

Due to their similarities in anatomy, physiology, and pharmacology to humans, mice are a valuable model system to study the generation and mechanisms modulating conventional outflow resistance and thus intraocular pressure. In addition, mouse models are critical for understanding the complex nature of conventional outflow homeostasis and dysfunction that results in ocular hypertension. In this review, we describe a set of minimum acceptable standards for developing, characterizing, and utilizing mouse models of open-angle ocular hypertension. We expect that this set of standard practices will increase scientific rigor when using mouse models and will better enable researchers to replicate and build upon previous findings.